SANGAMO THERAPEUTICS, INC. Earnings Per Share (Basic)
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Earnings Per Share (Basic) of -$0.08 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-14
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.08.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.11, a 320.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.08.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.14.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$0.44.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$0.49.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$1.48.
- SANGAMO THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$1.25.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$0.08 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$0.44 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$0.11 10-Q · filed 2025-11-06 | -$0.33 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.08 10-Q · filed 2025-08-07 | -$0.21 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | -$0.14 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$0.49 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $0.05 10-Q · filed 2025-11-06 | -$0.37 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.18 10-Q · filed 2025-08-07 | -$0.44 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.27 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$1.48 10-K · filed 2025-03-17 | |||
| 2023-09-30 | -$0.59 10-Q · filed 2024-11-12 | -$1.14 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.66 10-Q · filed 2024-08-06 | -$0.54 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $0.13 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.25 10-K · filed 2024-03-13 | |||
| 2022-09-30 | -$0.34 10-Q · filed 2023-11-01 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$0.93 10-Q · filed 2023-11-01 | |
| 2022-06-30 | -$0.29 10-Q · filed 2023-08-08 | -$0.59 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.30 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | -$1.23 10-K · filed 2024-03-13 | |||
| 2021-09-30 | -$0.33 10-Q · filed 2022-11-03 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.98 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.33 10-Q · filed 2022-08-04 | -$0.65 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$0.32 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$0.90 10-K · filed 2023-02-23 | |||
| 2020-09-30 | -$0.01 10-Q · filed 2021-11-04 | -$0.61 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$0.26 10-Q · filed 2021-08-05 | -$0.62 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | -$0.85 10-K · filed 2022-02-24 |